| | 103177-37-3 Basic information More.. |
| Product Name: | Pranlukast | | Synonyms: | PRANLUKAST;4-oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4h-1-benzopyranh;benzamide,n-(4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutox;emihydrate;ONO-RS-411;ONO-RS-411-01;N-[4-keto-2-(2H-tetrazol-5-yl)chromen-7-yl]-4-(4-phenylbutoxy)benzamide;N-[4-oxo-2-(2H-1,2,3,4-tetrazol-5-yl)chromen-7-yl]-4-(4-phenylbutoxy)benzamide | | CAS: | 103177-37-3 | | MF: | C27H23N5O4 | | MW: | 481.5 | | EINECS: | 808-178-9 | | Mol File: | 103177-37-3.mol |  |
Use
Pranlukast, a novel chromone derivative, was introduced in Japan for
the treatment of bronchial asthma and allergic diseases. Pranlukast is a highly potent,
selective and competitive antagonist of peptidoleukotrienes with high affinity for the
LTD4 receptor. In patients with bronchial asthma, pranlukast was reported to induce
significant improvement in both immediate and late asthmatic response induced by
antigen. Pranlukast is also being evaluated clinically for the treatment of perennial
allergic rhinitis, pediatric asthma, and cutaneous pruritus in dialysis patients. The
therapeutic potential of pranlukast in managing irritable bowel syndrome has been
suggested.
- Pranlukast
-
- US $0.00 / KG
- 2023-08-15
- CAS:103177-37-3
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 50000KG/month
- Pranlukast Hydrate
-
- US $0.00 / kg
- 2023-04-04
- CAS:103177-37-3
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1mt
- Pranlukast
-
- US $0.00 / KG
- 2021-11-15
- CAS:103177-37-3
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 200000pcs
|
|
103177-37-3
Recommend Suppliers |
|